These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 26834049)

  • 41. The Role of HMGB1 in Cardiovascular Biology: Danger Signals.
    Cai J; Wen J; Bauer E; Zhong H; Yuan H; Chen AF
    Antioxid Redox Signal; 2015 Dec; 23(17):1351-69. PubMed ID: 26066838
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High mobility group box 1 (HMGB1) levels in the placenta and in serum in preeclampsia.
    Wang B; Koga K; Osuga Y; Hirata T; Saito A; Yoshino O; Hirota Y; Harada M; Takemura Y; Fujii T; Taketani Y
    Am J Reprod Immunol; 2011 Aug; 66(2):143-8. PubMed ID: 21241404
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HMGB1 expression by activated vascular smooth muscle cells in advanced human atherosclerosis plaques.
    Inoue K; Kawahara K; Biswas KK; Ando K; Mitsudo K; Nobuyoshi M; Maruyama I
    Cardiovasc Pathol; 2007; 16(3):136-43. PubMed ID: 17502242
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Upregulation and nuclear localization of TNF-like cytokine 1A (TL1A) and its receptors DR3 and DcR3 in psoriatic skin lesions.
    Bamias G; Evangelou K; Vergou T; Tsimaratou K; Kaltsa G; Antoniou C; Kotsinas A; Kim S; Gorgoulis V; Stratigos AJ; Sfikakis PP
    Exp Dermatol; 2011 Sep; 20(9):725-31. PubMed ID: 21672030
    [TBL] [Abstract][Full Text] [Related]  

  • 45. During apoptosis HMGB1 is translocated into apoptotic cell-derived membranous vesicles.
    Schiller M; Heyder P; Ziegler S; Niessen A; Claßen L; Lauffer A; Lorenz HM
    Autoimmunity; 2013 Aug; 46(5):342-6. PubMed ID: 23194089
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inflammation triggers high mobility group box 1 (HMGB1) secretion in adipose tissue, a potential link to obesity.
    Gunasekaran MK; Viranaicken W; Girard AC; Festy F; Cesari M; Roche R; Hoareau L
    Cytokine; 2013 Oct; 64(1):103-11. PubMed ID: 23938155
    [TBL] [Abstract][Full Text] [Related]  

  • 47. HMGB1 in vascular diseases: Its role in vascular inflammation and atherosclerosis.
    de Souza AW; Westra J; Limburg PC; Bijl M; Kallenberg CG
    Autoimmun Rev; 2012 Oct; 11(12):909-17. PubMed ID: 22495229
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long pentraxin 3: a marker of inflammation in untreated psoriatic patients.
    Bevelacqua V; Libra M; Mazzarino MC; Gangemi P; Nicotra G; Curatolo S; Massimino D; Plumari A; Merito P; Valente G; Stivala F; La Greca S; Malaponte G
    Int J Mol Med; 2006 Sep; 18(3):415-23. PubMed ID: 16865225
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Elevated serum autoantibody against high mobility group box 1 as a potent surrogate biomarker for amyotrophic lateral sclerosis.
    Hwang CS; Liu GT; Chang MD; Liao IL; Chang HT
    Neurobiol Dis; 2013 Oct; 58():13-8. PubMed ID: 23639787
    [TBL] [Abstract][Full Text] [Related]  

  • 50. HMGB1 as a mediator of necrosis-induced inflammation and a therapeutic target in arthritis.
    Andersson U; Tracey KJ
    Rheum Dis Clin North Am; 2004 Aug; 30(3):627-37, xi. PubMed ID: 15261345
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High-mobility group box 1 represents a potential marker of disease activity and novel therapeutic target in systemic lupus erythematosus.
    Urbonaviciute V; Voll RE
    J Intern Med; 2011 Oct; 270(4):309-18. PubMed ID: 21793951
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Expressions and clinical significance of high mobility group box-1 mRNA and protein in laryngeal squamous cell carcinoma tissues and serum].
    Guo Y; Liu Y; Tan PQ; Li G; Su ZW; Tian YQ; Qiu YZ
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Jun; 47(6):487-90. PubMed ID: 22932142
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increased serum levels of high mobility group box 1 protein in patients with autistic disorder.
    Emanuele E; Boso M; Brondino N; Pietra S; Barale F; Ucelli di Nemi S; Politi P
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 May; 34(4):681-3. PubMed ID: 20302902
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Psoriatic lesional skin exhibits an aberrant expression pattern of interferon regulatory factor-2 (IRF-2).
    van der Fits L; van der Wel LI; Laman JD; Prens EP; Verschuren MC
    J Pathol; 2003 Jan; 199(1):107-14. PubMed ID: 12474233
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High mobility group box 1 protein is released by neural cells upon different stresses and worsens ischemic neurodegeneration in vitro and in vivo.
    Faraco G; Fossati S; Bianchi ME; Patrone M; Pedrazzi M; Sparatore B; Moroni F; Chiarugi A
    J Neurochem; 2007 Oct; 103(2):590-603. PubMed ID: 17666052
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HMGB1 Promotes Systemic Lupus Erythematosus by Enhancing Macrophage Inflammatory Response.
    Lu M; Yu S; Xu W; Gao B; Xiong S
    J Immunol Res; 2015; 2015():946748. PubMed ID: 26078984
    [TBL] [Abstract][Full Text] [Related]  

  • 57. HMGB1/RAGE induces IL-17 expression to exaggerate inflammation in peripheral blood cells of hepatitis B patients.
    Jhun J; Lee S; Kim H; Her YM; Byun JK; Kim EK; Lee SK; Cho ML; Choi JY
    J Transl Med; 2015 Sep; 13():310. PubMed ID: 26391982
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Downregulation of high mobility group box 1 attenuates the severity of acute lung injury in endotoxemic mice.
    Zhang X; Luan Z; Liang Y; Liu Y; Ma X
    Mol Med Rep; 2015 Jun; 11(6):4513-7. PubMed ID: 25625772
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serum peptides as putative modulators of inflammation in psoriasis.
    Matsuura T; Sato M; Nagai K; Sato T; Arito M; Omoteyama K; Suematsu N; Okamoto K; Kato T; Soma Y; Kurokawa MS
    J Dermatol Sci; 2017 Jul; 87(1):36-49. PubMed ID: 28431948
    [TBL] [Abstract][Full Text] [Related]  

  • 60. HMGB1: an overview of its versatile roles in the pathogenesis of colorectal cancer.
    Cheng KJ; Alshawsh MA; Mejia Mohamed EH; Thavagnanam S; Sinniah A; Ibrahim ZA
    Cell Oncol (Dordr); 2020 Apr; 43(2):177-193. PubMed ID: 31677065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.